ANDA 76030, held by Ani Pharms. Flecainide Acetate.
As of Nov 14, 2026, ANDA 76030 (Flecainide Acetate), held by Ani Pharms, was first approved by FDA on Oct 28, 2002, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 28, 2002 | Original application | Approved |
| Flecainide Acetate50MG · tablet;oral | Flecainide Acetate | Discontinued |
| Flecainide Acetate100MG · tablet;oral | Flecainide Acetate | Discontinued |
| Flecainide Acetate150MG · tablet;oral | Flecainide Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
